Bio-Techne (NASDAQ: TECH)
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-11-01 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 2.080 | 2.050 | -0.0300 | ||||
REV | 287.120M | 288.229M | 1.109M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Bio-Techne (NASDAQ: TECH) through any online brokerage.
Other companies in Bio-Techne’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Syneos Health (NASDAQ:SYNH) and Waters (NYSE:WAT).
The latest price target for Bio-Techne (NASDAQ: TECH) was reported by Wells Fargo on Tuesday, August 16, 2022. The analyst firm set a price target for 360.00 expecting TECH to fall to within 12 months (a possible -0.41% downside). 6 analyst firms have reported ratings in the last year.
The stock price for Bio-Techne (NASDAQ: TECH) is $361.47 last updated Today at August 17, 2022, 7:27 PM UTC.
A quarterly cash dividend of $0.32 per share of Class A Common Stock. The quarterly cash dividend was payable on August 29, 2022 to stockholders of record on August 12, 2022.
Bio-Techne’s Q1 earnings are confirmed for Tuesday, November 1, 2022.
There is no upcoming split for Bio-Techne.
Bio-Techne is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.